Evidence map›Paper›PMID 33837305›Full record

ArticleNature protocols2021

Identifying high-confidence capture Hi-C interactions using CHiCANE.

Erle M Holgersen, Andrea Gillespie, Olivia C Leavy, Joseph S Baxter, Alisa Zvereva, Gareth Muirhead, Nichola Johnson, Orsolya Sipos, Nicola H Dryden, Laura R Broome and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Read Mapping for Hi-C Analysis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Transcriptional enhancers and their communication with gene promoters.Cellular and molecular life sciences : CMLS · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Erle M Holgersen *The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Andrea Gillespie *The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Olivia C LeavyDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0002-1503-5535
Joseph S BaxterThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Alisa ZverevaThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0003-3535-029X
Gareth MuirheadThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Nichola JohnsonThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0002-8230-5662
Orsolya SiposThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Nicola H DrydenThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Laura R BroomeThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Yi ChenScientific Computing, The Institute of Cancer Research, London, UK.
Igor KozinScientific Computing, The Institute of Cancer Research, London, UK.
Frank DudbridgeDepartment of Health Sciences, University of Leicester, Leicester, UK.
Olivia FletcherThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Olivia.Fletcher@icr.ac.uk.ORCID http://orcid.org/0000-0001-9387-7116
Syed HaiderThe Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Syed.Haider@icr.ac.uk.ORCID http://orcid.org/0000-0001-6685-5480

Funding

Biotechnology and Biological Sciences Research Council BB/J004480/1Department of HealthMedical Research Council MR/L007150/1
6 · The paper itself

Abstract

The ability to identify regulatory interactions that mediate gene expression changes through distal elements, such as risk loci, is transforming our understanding of how genomes are spatially organized and regulated. Capture Hi-C (CHi-C) is a powerful tool to delineate such regulatory interactions. However, primary analysis and downstream interpretation of CHi-C profiles remains challenging and relies on disparate tools with ad-hoc input/output formats and specific assumptions for statistical modeling. Here we present a data processing and interaction calling toolkit (CHiCANE), specialized for the analysis and meaningful interpretation of CHi-C assays. In this protocol, we demonstrate applications of CHiCANE to region capture Hi-C (rCHi-C) and promoter capture Hi-C (pCHi-C) libraries, followed by quality assessment of interaction peaks, as well as downstream analysis specific to rCHi-C and pCHi-C to aid functional interpretation. For a typical rCHi-C/pCHi-C dataset this protocol takes up to 3 d for users with a moderate understanding of R programming and statistical concepts, although this is dependent on dataset size and compute power available. CHiCANE is freely available at https://cran.r-project.org/web/packages/chicane .

Indexed as

Enhancer Elements, GeneticEpigenomeGenomeGenomicsHistone CodeModels, GeneticMolecular Sequence AnnotationMutationPolymorphism, Single NucleotidePromoter Regions, GeneticQuantitative Trait LociRegulatory Sequences, Nucleic AcidRNA, MessengerStatistics as TopicRNA, Messenger

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.